Gene · 6480
Papers1,665
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,665
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Specific sialylation of N-glycans and its novel regulatory mechanism. | Glycoconj J | 2024 | 38958800 | PubTator, text mining | PubMed |
| Digitoxin inhibits ICC cell properties via the NF‑κB/ST6GAL1 signaling pathway. | Oncol Rep | 2024 | 38940341 | PubTator, text mining | PubMed |
| Novel genetically glycoengineered human dendritic cell model reveals regulatory roles of α2,6-linked sialic acids in DC activation of CD4+ T cells and response to TNFα. | Glycobiology | 2024 | 38873803 | PubTator, text mining | PubMed |
| Establishment of a humanized ST6GAL1 mouse model for influenza research. | Animal Model Exp Med | 2024 | 38859745 | PubTator, text mining | PubMed |
| Proteomic and metabolomic profiling of plasma predicts immune-related adverse events in older patients with advanced non-small cell lung cancer. | iScience | 2024 | 38827402 | PubTator, text mining | PubMed |
| Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone. | EBioMedicine | 2024 | 38772281 | PubTator, text mining | PubMed |
| Synthesis of α-Hydroxy-1,2,3-Triazole-linked Sialyltransferase Inhibitors and Evaluation of Selectivity Towards ST3GAL1, ST6GAL1 and ST8SIA2. | ChemMedChem | 2024 | 38758134 | PubTator, text mining | PubMed |
| Development of a Novel, Potent, and Selective Sialyltransferase Inhibitor for Suppressing Cancer Metastasis. | Int J Mol Sci | 2024 | 38673867 | PubTator, text mining | PubMed |
| Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells. | Cell Rep | 2024 | 38619967 | PubTator, text mining | PubMed |
| Glycoengineered recombinant alpha1-antitrypsin results in comparable in vitro and in vivo activities to human plasma-derived protein. | bioRxiv | 2024 | 38585818 | PubTator, text mining | PubMed |
| N-linked α2,6-sialylation of integrin β1 by the sialyltransferase ST6Gal1 promotes cell proliferation and stemness in gestational trophoblastic disease. | Placenta | 2024 | 38490094 | PubTator, text mining | PubMed |
| ST6GAL1 is associated with poor response to chemoradiation in rectal cancer. | Neoplasia | 2024 | 38467087 | PubTator, text mining | PubMed |
| Exploring candidate biomarkers for rheumatoid arthritis through cardiovascular and cardiometabolic serum proteome profiling. | Front Immunol | 2024 | 38420123 | PubTator, text mining | PubMed |
| Functions of Sialyltransferases in gynecological malignancies: A systematic review. | Pathol Res Pract | 2024 | 38306862 | PubTator, text mining | PubMed |
| Integration of network pharmacology, molecular docking, and simulations to evaluate phytochemicals from Drymaria cordata against cervical cancer. | RSC Adv | 2024 | 38292259 | PubTator, text mining | PubMed |
| Noninvasive serum N-glycans associated with ovarian cancer diagnosis and precancerous lesion prediction. | J Ovarian Res | 2024 | 38281033 | PubTator, text mining | PubMed |
| MMV_Im2Im: an open-source microscopy machine vision toolbox for image-to-image transformation. | Gigascience | 2024 | 38280188 | PubTator, text mining | PubMed |
| CD74 is associated with inflamed tumor immune microenvironment and predicts responsiveness to PD-1/CTLA-4 bispecific antibody in patients with solid tumors. | Cancer Immunol Immunother | 2024 | 38280003 | PubTator, text mining | PubMed |
| Altered O-linked glycosylation in benign and malignant meningiomas. | PeerJ | 2024 | 38274327 | PubTator, text mining | PubMed |
| Glycan Shape, Motions, and Interactions Explored by NMR Spectroscopy. | JACS Au | 2024 | 38274261 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6480/papers?page=7